- Home
- AAPG vs OMCL Comparison
AAPG vs OMCL Comparison
Compare AAPG & OMCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AAPG
- OMCL
- Stock Information
- Founded
- AAPG 2009
- OMCL 1992
- Country
- AAPG China
- OMCL United States
- Employees
- AAPG N/A
- OMCL N/A
- Industry
- AAPG Biotechnology: Pharmaceutical Preparations
- OMCL Computer Manufacturing
- Sector
- AAPG Health Care
- OMCL Technology
- Exchange
- AAPG Nasdaq
- OMCL Nasdaq
- Market Cap
- AAPG 1.7B
- OMCL 1.6B
- IPO Year
- AAPG 2025
- OMCL 2001
- Fundamental
- Price
- AAPG $23.04
- OMCL $35.26
- Analyst Decision
- AAPG Buy
- OMCL Buy
- Analyst Count
- AAPG 1
- OMCL 6
- Target Price
- AAPG N/A
- OMCL $51.00
- AVG Volume (30 Days)
- AAPG 26.1K
- OMCL 637.0K
- Earning Date
- AAPG 03-27-2025
- OMCL 05-01-2025
- Dividend Yield
- AAPG N/A
- OMCL N/A
- EPS Growth
- AAPG N/A
- OMCL N/A
- EPS
- AAPG N/A
- OMCL 0.27
- Revenue
- AAPG $134,352,180.00
- OMCL $1,112,238,000.00
- Revenue This Year
- AAPG $328.14
- OMCL $4.02
- Revenue Next Year
- AAPG N/A
- OMCL $4.32
- P/E Ratio
- AAPG N/A
- OMCL $130.41
- Revenue Growth
- AAPG 341.77
- OMCL N/A
- 52 Week Low
- AAPG $16.50
- OMCL $25.12
- 52 Week High
- AAPG $23.37
- OMCL $55.75
- Technical
- Relative Strength Index (RSI)
- AAPG N/A
- OMCL 45.08
- Support Level
- AAPG N/A
- OMCL $33.89
- Resistance Level
- AAPG N/A
- OMCL $35.37
- Average True Range (ATR)
- AAPG 0.00
- OMCL 1.11
- MACD
- AAPG 0.00
- OMCL 0.38
- Stochastic Oscillator
- AAPG 0.00
- OMCL 81.20
About AAPG Ascentage Pharma Group International American Depository Shares
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.
About OMCL Omnicell Inc. ($0.001 par value)
Omnicell Inc provides automation and business analytics software for healthcare providers. It helps its customers to define and deliver cost-effective medication management that is designed to equip and empower pharmacists and nurses to focus on patient care rather than administrative tasks, and to drive improved clinical, operational, and financial outcomes across all care settings. Omnicell generates the vast majority of its revenue in the United States.